SYH2069 Injection

DRUG2 trials

Sponsors

CSPC Ouyi Pharmaceutical Co., Ltd.

Conditions

DiabetesOverweight or Obesity

Phase 1

A Study of SYH2069 Injection in Healthy Participants

Active, not recruitingNCT07736391

CSPC Ouyi Pharmaceutical Co., Ltd.Diabetes, Overweight or Obesity

Start: 2026-01-10End: 2026-11-30Updated: 2026-07-30

Phase 2

Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.

Not yet recruitingNCT07803991

CSPC Ouyi Pharmaceutical Co., Ltd.Overweight or Obesity

Start: 2026-09-01End: 2027-12-31Target: 360Updated: 2026-09-04